Civil Circles

Pharmaceutical innovation can help Canadians in pain, and the economy

As Canadian MPs begin to identify their key priorities, it’s important to remember the painful impact rheumatoid arthritis has on Canadians and consider how government policies can help.

While there has been tremendous progress in the treatment of rheumatoid arthritis over the past two decades, more than two-thirds of treated patients still do not achieve clinical remission or low disease activity treatment targets, writes Lisa M. Olson. Photograph courtesy of Adobe Stock/AbbVie Canada

Opinion

BY LISA M. OLSON

November 20, 2019

Rheumatoid arthritis can debilitate bodies and crush spirits. It can also place a significant economic burden on individual patients, their families, and society. As the newest Canadian Members of Parliament take their seats to represent their constituents’ interests, this is an important time to ...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Fridays: Hill Life & People Newsletter

Itâ€™s all about the people: the latest on parliamentarians, political staff, and politicos.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy